RWS
CRL icon

Retirement Wealth Solutions’s Charles River Laboratories CRL Stock Holding History

Retirement Wealth Solutions’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.04K Buy
9
+1
+13% +$178 ﹤0.01% 526
2026
Q1 		$1.38K Sell
8
-1
-11% -$185 ﹤0.01% 579
2025
Q4 		$1.8K Buy
9
+2
+29% +$363 ﹤0.01% 473
2025
Q3 		$1.1K Buy
+7
New +$1.11K ﹤0.01% 546

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Retirement Wealth Solutions's CRL Position: Q2 2026 in Review

Retirement Wealth Solutions increased its Charles River Laboratories (CRL) stake by 13% in Q2 2026, buying an estimated $178 and bringing the position to 9 shares worth $2.04K. The position accounts for ﹤0.01% of the portfolio, ranked #526.

Retirement Wealth Solutions first reported a position in CRL in Q3 2025 and has held it in 4 quarters since. 563 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Retirement Wealth Solutions held 9 shares of Charles River Laboratories worth $2.04K as of Q2 2026.
  • Retirement Wealth Solutions bought 1 Charles River Laboratories share in Q2 2026, an estimated $178.
  • Charles River Laboratories made up ﹤0.01% of Retirement Wealth Solutions's portfolio in Q2 2026, its #526 holding.
  • Retirement Wealth Solutions first reported a position in Charles River Laboratories in Q3 2025 and has held it in 4 quarters since.
  • 563 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Retirement Wealth Solutions's 13F filing for Q2 2026, filed 7 Jul 2026.